Wealthcare Advisory Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
25,946
+8,808
+51% +$280K 0.02% 496
2026
Q1
$453K Sell
17,138
-2,669
-13% -$78.2K 0.01% 729
2025
Q4
$574K Buy
19,807
+3,480
+21% +$104K 0.01% 652
2025
Q3
$453K Buy
16,327
+649
+4% +$16.4K 0.01% 708
2025
Q2
$382K Buy
15,678
+590
+4% +$12.9K 0.01% 718
2025
Q1
$313K Sell
15,088
-815
-5% -$20.5K 0.01% 730
2024
Q4
$374K Buy
15,903
+435
+3% +$10.7K 0.01% 648
2024
Q3
$396K Sell
15,468
-1,815
-11% -$46.2K 0.01% 630
2024
Q2
$406K Buy
+17,283
New +$436K 0.01% 582
2022
Q2
Sell
-5,029
Closed -$231K 566
2022
Q1
$231K Sell
5,029
-1,005
-17% -$47.9K 0.01% 484
2021
Q4
$370K Sell
6,034
-336
-5% -$23.2K 0.02% 389
2021
Q3
$476K Sell
6,370
-1,306
-17% -$110K 0.03% 327
2021
Q2
$710K Sell
7,676
-1,313
-15% -$112K 0.05% 246
2021
Q1
$798K Buy
8,989
+2,560
+40% +$254K 0.06% 221
2020
Q4
$600K Buy
+6,429
New +$512K 0.05% 209
2020
Q2
Sell
-759
Closed -$24K 378
2020
Q1
$24K Buy
+759
New +$25.4K ﹤0.01% 683

Other funds holding ARKG

Wealthcare Advisory Partners's ARKG Position: Q2 2026 in Review

Wealthcare Advisory Partners increased its ARK Genomic Revolution ETF (ARKG) stake by 51% in Q2 2026, buying an estimated $280K and bringing the position to 25,946 shares worth $1.09M. The position accounts for 0.02% of the portfolio, ranked #496.

Wealthcare Advisory Partners first reported a position in ARKG in Q1 2020 and has held it in 16 quarters since. 47 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Wealthcare Advisory Partners held 25,946 shares of ARK Genomic Revolution ETF worth $1.09M as of Q2 2026.
  • Wealthcare Advisory Partners bought 8,808 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $280K.
  • ARK Genomic Revolution ETF made up 0.02% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #496 holding.
  • Wealthcare Advisory Partners first reported a position in ARK Genomic Revolution ETF in Q1 2020 and has held it in 16 quarters since.
  • 47 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.